Cytori Recognized By Frost & Sullivan For Medical Device And Regenerative Medicine Innovation
Frost & Sullivan awarded Cytori Therapeutics, Inc. (NASDAQ:CYTX) the 2008 North American Regenerative Medicine Technology Innovation of the Year Award and the 2008 United States Medical Device Industry Innovation & Advancement of the Year Award. The two distinct awards recognize Cytori’s development and commercialization of its Celution? System platform and its potential to dominate the practice of regenerative medicine.
More: continued here
Filed under: Medical Devices on March 3rd, 2008